Streetbeat News

Stock Prices

INTC

Intel Corp (NASDAQ: INTC) shares are trading slightly higher after a volatile period following disappointing Q2 earnings. The company reported earnings of 2 cents per share, missing the analyst estimate of 10 cents. In response, Intel announced a $10 billion cost-reduction plan, including a 15% workforce reduction and suspension of its dividend starting in Q4 2024. Analysts have mixed reactions, with BofA Securities downgrading the stock and others maintaining Neutral ratings but lowering price targets.

Portfolio Pulse from Henry Khederian

August 07, 2024 | 4:27 pm

BLD

TopBuild shares are trading lower after Truist Securities maintained a Hold rating and lowered its price target from $410 to $395. Evercore ISI Group also maintained an Outperform rating but lowered its price target from $555 to $489.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 4:27 pm

NYT

New York Times Company (NYSE:NYT) shares are trading higher after reporting strong Q2 financial results. The company beat earnings estimates with 45 cents per share and saw a 5.78% year-over-year increase in sales to $625 million. NYT added 300,000 net digital-only subscribers, driving a 12.9% increase in digital subscription revenues and a 7.8% increase in digital advertising revenues. The stock is up 5.12% following the report.

Portfolio Pulse from Erica Kollmann

August 07, 2024 | 4:26 pm

ABNB

Airbnb Inc (NASDAQ:ABNB) shares dropped significantly after reporting disappointing Q2 earnings. Multiple analysts have cut their price targets, citing concerns over margin contraction, increased marketing costs, and slowing demand. The company's Q3 guidance also fell short of expectations, leading to a negative outlook for the near term.

Portfolio Pulse from Priya Nigam

August 07, 2024 | 4:24 pm

LLY

NVO

Eli Lilly and Company (NYSE: LLY) shares are trading lower ahead of its anticipated 2024 fiscal year earnings release. Analysts estimate an EPS of $2.70 and sales of $9.94 billion. Despite missing revenue estimates last quarter, Eli Lilly has consistently beaten EPS estimates in recent reports. The company's weight-loss drug Zepbound has captured significant market share since its December launch. Analysts have recently adjusted their price targets for Eli Lilly, with Cantor Fitzgerald maintaining an $885 target and Guggenheim raising its target to $884.

Portfolio Pulse from Dylan Berman

August 07, 2024 | 4:22 pm

LLY

Eli Lilly shares are trading lower in sympathy with Novo Nordisk, which fell after reporting Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 4:21 pm

GO

Grocery Outlet Holding Corp (NASDAQ:GO) reported better-than-expected Q2 results, with earnings of 25 cents per share and sales of $1.13 billion. Despite the positive results, analysts from Telsey Advisory Group and UBS lowered their price targets for the stock. The company also announced plans for 62-64 new store openings in FY24.

Portfolio Pulse from Avi Kapoor

August 07, 2024 | 4:20 pm

DVN

Devon Energy shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 4:19 pm

BA

Deep-pocketed investors have shown significant interest in Boeing (NYSE:BA) options, with a mix of bullish and bearish sentiments. Benzinga's options scanner highlighted 42 extraordinary options activities for Boeing, indicating potential big moves. Analysts have mixed ratings on Boeing, with price targets ranging from $185 to $235.

Portfolio Pulse from Benzinga Insights

August 07, 2024 | 4:16 pm

CPNG

Coupang shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 4:16 pm